Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma
Authors:
- Ian C. MacArthurIMIan C. MacArthur
- Yi BeiYBYi Bei
- Michael V. OrtizMOMichael V. Ortiz
- Joern ToedlingJTJoern Toedling
- Filippos KlironomosFKFilippos Klironomos
- Jana RolffJRJana Rolff
- Angelika EggertAEAngelika Eggert
- Johannes H. SchulteJSJohannes H. Schulte
- Alex KentsisAKAlex Kentsis
- Anton G. HenssenAHAnton G. Henssen
Open Access
- 16 May 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (10)
Abstract
Gain of the long arm of chromosome 17 (17q) is a cytogenetic hallmark of high-risk neuroblastoma, yet its contribution to neuroblastoma pathogenesis remains incompletely understood. Combining whole-genome and RNA sequencing of neuroblastomas, we identified the prohibitin (PHB) gene as highly expressed in tumors with 17q gain. High PHB expression correlated with poor prognosis and was associated with loss of gene expression programs promoting neuronal development and differentiation. PHB depletion induced differentiation and apoptosis and slowed cell cycle progression of neuroblastoma cells, at least in part through impaired ERK1/2 activation. Conversely, ectopic expression of PHB was sufficient to increase proliferation of neuroblastoma cells and was associated with suppression of markers associated with neuronal differentiation and favorable neuroblastoma outcome. Thus, PHB is a 17q oncogene in neuroblastoma that promotes tumor cell proliferation and dedifferentiation.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (398299703)
- National Institutes of Health (R01 CA214812)
- National Institutes of Health (P30 CA008748)
This publication has 62 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membraneOncogene, 2012
- A public genome-scale lentiviral expression library of human ORFsNature Methods, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Localization of Prohibitin in the Nuclear Matrix and Alteration of Its Expression During Differentiation of Human Neuroblastoma SK-N-SH Cells Induced by Retinoic AcidCellular and Molecular Neurobiology, 2010
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease OutcomeCell, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repressionOncogene, 2002
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999